Home LiteratureArticle Details
PMID: 3216298 Published · ppublish English Journal Article

Interim report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic: Chairman's recommendations--Part I.

Journal of acquired immune deficiency syndromes ·Vol. 1 ·No. 1 ·1988-00-00 ·Pages 69-103

Watkins JD, Conway-Welch C, Creedon JJ, Crenshaw TL, DeVos RM, Gebbie KM, Lee BJ, Lilly F, O'Connor JC, Primm BJ

Abstract

暂无摘要

Keywords
Health Care and Public Health Presidential Commission on Human Immunodeficiency Virus Epidemic Acquired Immunodeficiency Syndrome Americas Delivery Of Health Care Developed Countries Diseases Drugs Economic Factors Education Foundations Government Agencies Government Sponsored Programs Health Health Education Health Personnel Hiv Infections North America Northern America Organization And Administration Organizations Policy Programs Recommendations Research And Development Social Problems Substance Addiction Technology Treatment United States Usphs Viral Diseases
MeSH Terms
Acquired Immunodeficiency Syndrome/epidemiology,prevention & control,therapy Advisory Committees Biomedical Research Disease Outbreaks Federal Government Health Policy Humans Research United States
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Watkins J D
Conway-Welch C
Creedon J J
Crenshaw T L
DeVos R M
Gebbie K M
Lee B J
Lilly F
O'Connor J C
Primm B J
Other Abstracts
eng

The Presidential Commission was created in September 1987 with the mandate to advise the White House "on the public health dangers including the medical, legal, ethical, social, and economic impact, from the spread of the HIV and resulting illnesses including AIDS, AIDS related complex, and other related conditions." This paper covers the Commission's interim policy recommendations as of March 15, 1988, in the areas of intravenous drug abuse, patient care, and basic research and drug development. The scope of recommendations in the area of intravenous drug abuse includes provision of treatment services, treatment research, drug abuse prevention, and outreach education. There must be a national policy of "treatment on demand" for drug users. An expanded program of drug treatment research must include research on cocaine as well as heroin addiction treatment. Drug abuse prevention should coordinate efforts at all levels of government as well as community and religious organizations and schools. Outreach education, which is especially difficult with drug users because drug use is illegal, will cost roughly $126.5 million a year over current funding. Outreach programs should train and utilize street outreach workers, including former addicts, and should have special focuses on adolescents, minorities, and women of childbearing age. The scope of recommendations in the area of patient care includes health care provider education, health care systems, psychosocial needs, nursing care, minorities and underserved populations, and information coordination and exchange. AIDS needs to be integrated into the educational curricula of medical and all other health professional schools. In the area of health care systems, the recommendations emphasize the need for integrated community-based services for people with HIV infection. 22 AIDS Service Delivery Demonstration projects are currently being conducted in the US, 13 funded by the US Public Health Service and 9 funded by the Robert Wood Johnson Foundation.

Article Info
Journal
Journal of acquired immune deficiency syndromes
Abbr.
J Acquir Immune Defic Syndr (1988)
ISSN
0894-9255
Published
1988-00-00
Pages
69-103
Language
English
Region
United States
NLM ID
8812597
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]